Transcriptomic analysis reveals the lipid metabolism-related gene regulatory characteristics and potential therapeutic agents for myocardial ischemia-reperfusion injury.

Publication Year: 2024

DOI:
10.3389/fcvm.2024.1281429

PMCID:
PMC10859419

PMID:
38347951

Journal Information

Full Title: Front Cardiovasc Med

Abbreviation: Front Cardiovasc Med

Country: Unknown

Publisher: Unknown

Language: N/A

Publication Details

Subject Category: Cardiac & Cardiovascular Systems

Available in Europe PMC: Yes

Available in PMC: Yes

PDF Available: No

Transparency Score
3/6
50.0% Transparent
Transparency Indicators
Click on green indicators to view evidence text
Core Indicators
Data Sharing
Code Sharing
Evidence found in paper:

"Conflict of interest The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest."

Evidence found in paper:

"The authors declare financial support was received for the research, authorship, and/or publication of this article.This study was supported by the Natural Science Foundation of Hubei Province (grant no. 2020CFB672, Wei Wu)."

Protocol Registration
Open Access
Paper is freely available to read
Additional Indicators
Replication
Novelty Statement
Assessment Info

Tool: rtransparent

OST Version: N/A

Last Updated: Aug 05, 2025